![N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide structure](/static/products/514/514855-40-4.png)
N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide
TL;DR: N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide (CAS 514855-40-4) is a chemical compound with molecular formula C25H20N4O5 and molecular weight 456.14 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide
Also Known As: N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide, 3-nitro-N'-{4-methoxy-3-[(8-quinolinyloxy)methyl]benzylidene}benzohydrazide, N'-[(E)-{4-methoxy-3-[(quinolin-8-yloxy)methyl]phenyl}methylidene]-3-nitrobenzohydrazide, N-{(1E)-2-[4-methoxy-3-(8-quinolyloxymethyl)phenyl]-1-azavinyl}(3-nitrophenyl) carboxamide
| Molecular Formula | C25H20N4O5 |
|---|---|
| Molecular Weight | 456.14 g/mol |
| LogP | 4.4945 |
| Topological Polar Surface Area | 115.95 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Exact Mass | 456.14337 |
| Heavy Atoms | 34 |
| Complexity | 1381.6145 |
Chemical Identifiers
| CAS Number | 514855-40-4 |
|---|---|
| SMILES | COC1=C(C=C(C=C1)/C=N/NC(=O)C2=CC(=CC=C2)[N+](=O)[O-])COC3=CC=CC4=C3N=CC=C4 |
Product Overview
N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide (CAS 514855-40-4), with molecular formula C25H20N4O5 and molecular weight 456.14 g/mol. IUPAC: N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide.
Chemical Property Profile of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide
Property Insights of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide
The XLogP value of 4.4945 indicates that N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 115.95 Ų falls within the moderate polarity range, balancing permeability and solubility for N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide. Following Lipinski's Rule of Five, N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide?
The CAS number of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide is 514855-40-4.
What is the molecular formula of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide?
The molecular formula of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide is C25H20N4O5.
What is the molecular weight of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide?
The molecular weight of N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide is 456.14 g/mol.
Where can I buy N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide?
You can request a quote for N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide?
Yes, KEHONG BIO provides custom synthesis services for N-[(E)-[4-methoxy-3-(quinolin-8-yloxymethyl)phenyl]methylideneamino]-3-nitrobenzamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.